PPARGC1A and gestational diabetes: The primary strength of our study is revealing how the genetic effect of PPARGC1A rs8192678 on GDM slightly changes with urinary BPA and serum TSH level in a nested case–control design, which is based on a prospective cohort of nearly 3,000 pregnant women and highly efficient for avoiding reverse causation.